Medically Reviewed by: Dr. Dipak Ladda, M.D.
Expertise: Consultant Pathologist
Last Updated: July 16, 2026
Medical Analysis
Understanding the Indirect Coombs’ Test (ICT) in Hematology
The Indirect Coombs’ Test (ICT), also known as the Indirect Antiglobulin Test (IAT), is a critical diagnostic procedure in hematology used to detect the presence of unbound antibodies in a patient’s serum that are directed against red blood cell (RBC) antigens [3, 4]. By identifying these circulating, unattached antibodies, the test helps clinicians predict potential hemolytic reactions, making it an indispensable tool in transfusion medicine and prenatal care [6, 11]. The process relies on the use of Coombs’ Reagent—a broad-spectrum anti-human globulin (AHG) produced in rabbits or goats specifically to recognize and bind to human immunoglobulins [4, 9].
The Scientific Principle of the Indirect Antiglobulin Test
The fundamental principle of the ICT is to detect free-floating IgG antibodies within a patient’s serum that have the potential to attack the body’s own RBC antigens [5, 12]. Unlike the direct test, which looks for antibodies already attached to cells, the indirect test facilitates the sensitization of RBCs with these “incomplete” antibodies in an in vitro environment [5, 12].
When these specific antibodies encounter target RBCs, they bind to the surface, creating sensitized erythrocytes [4, 13]. The addition of the AHG reagent then targets the Fc portion of the human IgG antibodies already attached to the cells [12]. This interaction creates a visible latticework or clumping of RBCs, known as agglutination, which serves as the visual confirmation of a positive result [3, 4].
Comparing Indirect and Direct Coombs’ Tests
While both procedures fall under the umbrella of the Coombs’ test, they serve distinct diagnostic purposes.
Direct Coombs’ Test: Used to detect IgG antibodies that are already attached to the surface of RBCs in vivo [3, 12].
Indirect Coombs’ Test: Used to detect free-floating IgG antibodies in the serum through in vitro sensitization [5, 12].
Clinical Indications for ICT
The application of the Indirect Coombs’ Test is broad and serves several essential clinical functions:
Pre-natal Testing: Critical for screening pregnant women to prevent complications [7, 13].
Recurrent Miscarriage and Stillbirth: Investigating immunological causes for pregnancy loss [7].
Compatibility Testing: Ensuring donor blood is compatible with the recipient to avoid life-threatening hemolytic reactions [4, 14].
Screening and Identification: Detecting unexpected antibodies in the serum [3, 10].
Rare Blood Group Determination: Assisting in identifying specific RBC phenotypes [2, 13].
Transfusion Monitoring: Helping to monitor and prevent future post-transfusion reactions [6, 11].
Procedural Requirements and Pre-Test Precautions
To ensure the accuracy of the Indirect Coombs’ Test, strict adherence to collection and handling protocols is required [4].
Sample Collection: 3.0 ml of patient blood must be collected in a plain tube (red-capped). Serum should be separated as quickly as possible [3, 4].
Reagents: Requires reagent red cells (specifically from O blood group donors), anti-human globulin (AHG), and normal saline [4, 9].
Equipment: Centrifuge, test tubes, and an incubator set to 37 degrees Celsius [4].
Important Precautions:
Avoid hemolysis during collection, as it interferes with test results [4, 9].
Use fresh samples, ideally within 24 hours [4].
Minimize the impact of recent blood transfusions if possible [11].
Keep samples at room temperature; avoid refrigeration before the test [4].
Be aware that medications, such as immunosuppressants or monoclonal antibodies, can affect results [1, 4].
Always use appropriate positive and negative controls for validation [4, 9].
Laboratory Procedure for ICT
The diagnostic process follows a standardized clinical protocol to ensure reliability [4].
Preparation: Mix 3 drops of patient serum with 3 drops of 5% pooled O group RBCs [4, 9].
Incubation: Incubate the mixture at 37 degrees Celsius for 30 minutes [4].
Initial Centrifugation: Centrifuge at 1000 rpm for 1 minute and check for immediate agglutination [4].
AHG Addition: If the initial result is negative, add 2 drops of AHG reagent [4].
Final Centrifugation: Centrifuge at 1500 rpm for 1 minute and observe for haemagglutination [4].
Validation: If results remain negative, add pre-sensitized reagent cells; agglutination must occur with the addition of Coombs’ control cells to prove the test is valid [4].
Results Interpretation:
Agglutination: Positive result (antibodies detected) [4, 12].
No Agglutination: Negative result (no antibodies detected) [4, 12].
Clinical Utility and Limitations Table
| Application | Clinical Context |
| Blood transfusion compatibility | Detects alloantibodies to prevent hemolytic transfusion reactions [6, 14] |
| Prenatal antibody screening | Screens pregnant women to detect IgG antibodies that cause HDFN [7, 13] |
| Autoimmune hemolytic anemia | Supports AIHA diagnosis by detecting free autoantibodies in serum [1, 8] |
| Antibody identification | Identifies specific RBC antibodies to guide antigen matching [2, 10] |
Clinical Limitations:
Low-affinity antibodies may escape detection [4, 10].
Inadequate washing can lead to false-negative results [4].
Complement inactivation may impact accuracy [4].
The test requires meticulous technique and experienced observation [4, 9].
Lower antibody titers may not always reach the threshold of sensitivity [4, 10].
For Non-Medicos
Understanding the Indirect Coombs’ Test
When a doctor orders an Indirect Coombs’ Test (ICT), they are checking your blood for hidden troublemaker proteins called antibodies [3, 5]. These proteins are floating in the liquid part of your blood (serum) and, if present, could attack your red blood cells or someone else’s if you were to receive a blood transfusion [6, 11].
Why is this test performed?
This test acts like a safety shield [6]. It is most commonly used to ensure that blood given during a transfusion won’t cause a bad reaction, and it is also vital during pregnancy to make sure the mother’s immune system isn’t reacting against the baby’s blood [7, 14].
What happens during the test?
Sample: The lab needs a small sample of your blood collected in a plain tube [4].
Process: Scientists mix your blood serum with special test cells to see if your antibodies try to stick to them (clump together) [4, 12].
Numbing/Special Prep: While the test itself happens in the lab, no special preparation is needed for you other than providing the blood sample [4].
What do the results mean?
Positive Result: This means antibodies were found in your blood [4]. In pregnancy, it means the mother is sensitized [7]. Doctors may suggest special treatments (like a specific injection) to protect the baby [7].
Negative Result: This is generally good news, indicating no major antibodies were found that would cause immediate reactions during a transfusion or pregnancy [4, 14].
Key Takeaways for Patients
Precision Matters: Because the test looks for tiny, floating proteins, small errors like using old blood or cold samples can change the result [4]. That is why following the lab’s instructions before your blood draw is very important [4].
Clinical Guidance: If your test comes back positive, do not panic [4]. It simply gives your doctor the missing link they need to make the best decisions for your care, such as selecting the safest possible blood for you or taking steps to protect a pregnancy [7, 11].
References:
Petz, L. D., & Garratty, G. (2024). Immune Hemolytic Anemias. Elsevier.
Daniels, G. (2025). Human Blood Groups. Wiley-Blackwell.
Harmening, D. M. (2024). Modern Blood Banking & Transfusion Practices. F.A. Davis Company.
Fung, M. K., et al. (2025). Technical Manual. AABB (Association for the Advancement of Blood & Biotherapies).
Westhoff, C. M. (2024). The Indirect Antiglobulin Test. Transfusion Medicine Reviews.
Franchini, M., & Lippi, G. (2025). The indirect Coombs test: Still a cornerstone of transfusion medicine. Journal of Blood Medicine.
Sandler, S. G., et al. (2025). Diagnosis and management of hemolytic disease of the fetus and newborn. Blood Reviews.
Hill, Q. A., et al. (2024). Diagnosis and management of autoimmune hemolytic anemia. Haematologica.
Judd, W. J. (2025). Methods in Immunohematology. American Society for Clinical Pathology.
Menis, S., et al. (2024). Advances in antibody detection techniques in transfusion medicine. Transfusion and Apheresis Science.
Tormey, C. A., & Hendrickson, J. E. (2025). Transfusion reactions: Diagnosis and management. Hematology/Oncology Clinics.
Garratty, G. (2024). The role of the antiglobulin test in the diagnosis of immune hemolytic anemia. Transfusion.
Reid, M. E., et al. (2025). The Blood Group Antigen FactsBook. Academic Press.
Cooling, L. (2026). Pretransfusion Testing: Then and Now. Immunohematology Journal.
FAQ’s:
What is the ICT?
It is a diagnostic test detecting free-floating antibodies in patient serum against red blood cell antigens.How does ICT work?
Serum antibodies sensitize reagent RBCs, which are then cross-linked by Coombs’ reagent to produce visible agglutination.What is Coombs’ reagent?
It is broad-spectrum anti-human globulin (AHG) produced in rabbits or goats to detect human immunoglobulins.Why is ICT performed?
It screens for blood transfusion compatibility, prenatal Rh incompatibility, and autoimmune hemolytic anemia diagnoses.What samples are needed?
The test requires patient serum, donor-pooled “O” group reagent RBCs, and anti-human globulin (AHG) reagent.How is ICT performed?
Serum and reagent RBCs are incubated at 37°C, centrifuged, and checked for agglutination after adding AHG.What is a positive result?
Visible haemagglutination after adding AHG indicates a positive result, confirming the presence of significant antibodies.What affects ICT accuracy?
Hemolysis during collection, refrigeration, recent medications, or inadequate cell washing can compromise test accuracy.What if ICT is positive?
It indicates maternal sensitization; doctors then use passive immunization to prevent pregnancy-associated fetal complications.What are test limitations?
Limitations include potential failure to detect low-affinity antibodies and the requirement for highly meticulous laboratory technique.
